HPAPI Market Share 2022: Trends, Key Players, Industry Analysis and Forecast 2022-2028

The global high potency active pharmaceutical ingredient (HPAPI) market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The major factor driving the demand for the global high potency active pharmaceutical ingredients (HPAPI) market during the forecast period is the increasing demand for these drugs across the globe. The global HPAPI market is growing especially after the COVID-19 pandemic due to which governments focus on pharmaceutical raw materials like high potency active ingredients which drive the growth of the market.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/high-potency-active-pharmaceutical-ingredients-hpapi-market

Furthermore, targeted therapy is getting popular as compared to drugs or chemotherapy as it does not harm non-cancerous cells. Moreover, the growth of the market is also attributed to the increasing prevalence of cancer. According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Furthermore, there were 18.1 million new cases globally in 2018 which is anticipated to rise to 29.5 million by 2040.

In addition, investment by pharmaceutical companies in R&D activities for expanding the HPAPI manufacturing sites and developing potent drugs will boost the market growth. For instance, in September 2020, Merck announced $65.2 million for the expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, US. However, special containment facilities require significant investment, transporting, and managing HPAPI which is extremely dangerous and costly as well as toxic to the health of associates working in manufacturing centers. These are some factors that act as a restriction for the growth of the global HPAPI market.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028

Segment Covered- 

  • By Type
  • By Type of Synthesis
  • By Application

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- including BASF SE, Corden Pharma International GmbH, Cambrex Corp., CARBOGEN AMCIS AG, Dr. Reddy’s Laboratories Ltd., and Others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How has COVID-19 impacted the market?

o             Deviation from the pre-COVID-19 forecast

o             Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report Segment

By Type

  • Innovative HPAPI
  • Generic HPAPI

By Type of Synthesis

  • Synthetic HPAPI
  • Biotech HPAPI

By Application

  • Oncology
  • Glaucoma
  • Hormonal Disorder
  • Others (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)

A full report of HPAPI Market is available at: https://www.omrglobal.com/industry-reports/high-potency-active-pharmaceutical-ingredients-hpapi-market

HPAPI Market– Segment by Region

North America          

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific   

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa
  • Latin America

Company Profiles

  • Ajinomoto Bio-Pharma Services
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb
  • Curia Global, Inc.
  • Cipla Ltd.
  • Eli Lilly and Company
  • Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Merck & co. Inc.
  • Mylan Laboratories Ltd.
  • Novartis AG
  • Pfizer, Inc.

 

Reasons to Buying From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research